ATC than in the primary tissues. Immunohistochemistry (n = 10) showed that ATC also had much higher expression of phosphorylated SMAD2 than that in the corresponding primary tissues. TGF-beta 1 was detected in all cases of malignant ascites by enzymelinked immunoassay (n = 38), suggesting the possible interaction of ATC and the ascites microenvironment. In vitro experiments revealed that these ATC properties were maintained by TGF-beta 1 in cultured ATC(n = 3). Here, we showed that ATCrevealed high frequencies of CD44 and possessed distinct EMT features from primary tissues that were mainly maintained by TGF-beta 1 in the ascites.
quantified the frequency of each cellular component in malignant ascites and biologically characterized ascites tumor cells (ATC) and ascites microenvironment cells (AMC) using flow cytometry in 65 patients with malignant ascites.
Because ATC detached from primary tissues are free of intercellular contact and float in ascites fluid in association with AMC, soluble factors such as vascular endothelial growth factor and interleukin 6 in ascites fluid are thought to affect the biology of ATC. 4 The specific tumor microenvironment in malignant ascites may determine the ATC features, which lead to their survival, proliferation and metastasis. Epithelial-mesenchymal transition (EMT) is a complex process through which cells acquire metastatic ability. During the EMT process, cancer cells become invasive and metastatic without intercellular contact by losing the epithelial phenotype and acquiring the mesenchymal phenotype. 5 The EMT proceeds by several signaling pathways, such as transforming growth factor beta (TGF-beta) signaling, and can regulate essential EMT-inducing transcription factors (EMT-TF), such as Snail, Twist and zinc finger E-box binding homeobox (ZEB) families. 6 As a result of activation of the EMT-TF by their upstream TGF-beta signaling pathway, cancer cells acquire invasive and metastatic ability.
Accumulating evidence suggests that EMT-TF are closely associated with the generation of cancer stem cells (CSC). 7, 8 CSC are generally identified by the expression of cell surface makers, including CD44 in colorectal cancer, 9 pancreatic cancer, 10 gastric cancer 11 and other types of cancer, 12 and are responsible for tumor propagation and invasive metastasis. Overexpression of EMT-TF and external stimulation with TGF-beta in non-CSC induced CD44 + CSC-like cells in in vitro and in vivo experiments. 13, 14 In addition, CD44 itself contributes to the metastatic ability, indicated by analysis of overexpression and short hairpin RNA of CD44. 15 These reports indicate that high CD44 expression correlates with CSC and the EMT phenotype, which are regulated by the tumor microenvironment through several signaling pathways, including the TGF-beta signaling pathway. 7, 8 However, the relationship between the biological features of ATC and their microenvironment has not been fully investigated in malignant ascites. Here, we report the specific biology of ATC in terms of the EMT and CSC by evaluating the contribution of ascites microenvironment. 
| MATERIALS AND METHODS

| Ethics statement
| Primary tissues
Surgical resected tumor specimens were washed twice in PBS, minced with a razor blade, and incubated with type 3 collagenase (Worthington Biochemicals, Lakewood, NJ, USA) and DNAase I (Wako Chemicals) for 60 minutes at 37°C using the gentleMACS Dissociator. After enzymatic digestion, the sample was sequentially filtered through a 100 μmol/L and 40 μm cell strainer (Corning, Corning, NY, USA), and the cells were incubated with BD Pharm Lyse Lysing Buffer (BD Biosciences) for 5 minutes to lyse red blood cells. 
| Flow cytometry and cell sorting
| Primary culture of ascites tumor cells
Ascites tumor cells were purified by cell sorting using the cell surface marker EpCAM as previously described. Sorted EpCAM + cells were resuspended in RPMI-1640 medium (Wako Chemicals, Richmond, VA, USA) supplemented with 10% FBS (Nichirei, Tokyo, Japan) and 1% penicillin/streptomycin (Life Technologies, Carlsbad, CA, USA), and were incubated at 37°C.
| Enzyme-linked immunoassay
The amounts of total TGF-beta 1 in the supernatant of ascites fluid were measured using the LEGEND MAX Total TGF-beta 1 ELISA Kit according to the manufacturer's instructions (BioLegend).
| Immunohistochemistry
Immunohistochemistry ( 
| RNA isolation and quantitative PCR assay
Total RNA was extracted using TRIzol Reagent (Thermo Fisher Scientific, Waltham, MA, USA) in accordance with the manufacturer's instructions, and cDNA synthesis was performed using the reverse transcriptase SuperScript III First-Strand Synthesis System (Thermo Fisher Scientific). Quantitative PCR (qPCR) was performed using the
StepOnePlus Real-time PCR System. Multiplex qPCR of ATC and primary tissues was performed using the TaqMan PreAmp Master Mix (Applied Biosystems, Foster City, CA, USA), and cDNA samples were subjected to qPCR using the BioMark system (Fluidigm, San Francisco, CA, USA) as previously reported. 16 Reactions were run in triplicate in 3 independent experiments. The geometric mean of the housekeeping gene GAPDH was used as the internal control. All reagents and instruments, if not otherwise stated, were from Applied Biosystems.
| Primers and probes
Taqman gene expression assays were purchased from Applied Biosys- 
| Sphere-forming assay
Cultured ATC were suspended as single cells and inoculated into nitrogen-supplemented DMEM/F12 medium without serum at a density of 1 × 10 4 cells/well in ultra-low attachment 24-well plates. Aliquots of human recombinant epidermal growth factor (EGF; 10 ng/ mL) and basic fibroblast growth factor (bFGF; 10 ng/mL) were added.
After culturing for 10-14 days, colonies containing >10 cells were quantified.
| Statistical analysis
All experiments were performed in triplicate, and data are expressed as the median ± standard deviation unless otherwise indicated. For statistical analysis, Student's t test and one-way analysis of variance were performed. Statistically significant differences are indicated by asterisks (*P < 0.05; **P < 0.01; ***P < 0.001).
| RESULTS
| Flow cytometric analysis revealed ascites consisted of ascites tumor cells and ascites microenvironment cells
In malignant ascites, cancer cells float in the ascites fluid, which is composed of several cell types. Fluorescence-activated cell sorting (FACS)-based quantification has been used as a tool to reveal the population of cells consisting of malignant ascites. 3, 17 We performed FACS analysis of malignant ascites obtained from 65 patients, including 26 gastric cancer patients, 24 colorectal cancer patients, 14 pancreatic cancer patients, and 1 patient with "other" tumor (Table S1 ).
First, we quantified the frequency of ATC (EpCAM
, and blood cells (CD45+) in the whole cells of the ascites ( Figure 1A ). While the mean frequency of ATC was 11.3% ± 6.3% (mean ± 95% confidence interval), the cellular components of the malignant ascites were dominated by CD45 + blood cells 
| Ascites tumor cells express CD44 with high frequency
To evaluate the specific properties of ATC compared with primary cancer cells, we focused on the CD44-expressing tumor cells. We Figure 2A ). To confirm these results, the frequency of CD44-positive ATC or primary cells obtained from the same patients was analyzed by FACS analysis ( Figure 2B , n = 1; colorectal cancer) and IHC ( Figure 2C , n = 10; 2 colorectal cancer, 7 gastric cancer and 1 pancreatic cancer). Higher frequency of CD44 and higher intensity of fluorescence was observed in ATC by FACS (n = 1, Figure 2B ). In IHC, ATC, which were larger than the other blood cells, were positive for CD44 (>90%) in almost all of the samples, but CD44 expression in the primary cells was only focally positive, as expected ( Figure 2C ).
The quantitative IHC score revealed that CD44 expression was higher in ATC than in primary cells in all cases (10/10; Figure 2C and were differences in expression of EMT-TF between ATC and primary tissues. Higher expression of ZEB1, ZEB2, SNAI2 and TWIST2 was observed in ATC; however, SNAI1 and TWIST1 were more highly expressed in primary tissues than in ATC ( Figures 3B and S3B ). In contrast, similar expression levels of epithelial markers such as EpCAM, Ecadherin and CEACAM5 were detected in both samples ( Figure S4 ).
Significant differences in ZEB1 expression were confirmed by IHC in identical pairs of ATC and primary tissues (n = 10). ATC in 9 of 10 patients (90%) were positive for ZEB1, but primary tissues in only 4 of 10 (40%) of the same patients were positive for ZEB1 ( Figure 3C and Table 1 ). These results indicated that ATC possessed mesenchymallike features, which were regulated by certain EMT-TF.
| Transforming growth factor beta 1 is abundantly released from the ascites microenvironment
We confirmed the ATC-specific phenotype with high frequency of CD44 ( Figure 2 ) and mesenchymal-like features ( Figure 3 ). We Type  CD44 primary  CD44 ATC  ZEB1 primary  ZEB1 ATC  pSMAD2 primary  pSMAD2 ATC   A18  49  m  Pancreatic  0  3  1  1  0  3   A27  63  m  Gastric  0  3  2  1  2  3   A28  82  m  Gastric  1  3  0  0  0  3   A31  68  m  Gastric  1  2  1  2  0  3   A32  74  f  Gastric  2  3  0  2  1  3   A66  76  m  Gastric  3  3  0  2  1  3   A68  61  f  Gastric  1  3  1  2  1  3   A82  51  m  Gastric  0  3  0  2 and ZEB2 was higher in malignant ascites (n = 15; black dots for gastric cancer, red dots for colorectal cancer, blue dots for pancreatic cancer) than in primary tissues (n = 15; black dots for gastric cancer and red dots for colorectal cancer), as determined by qPCR. Two-tailed Student's t test was used for statistical analysis. ***P < 0.001. B, Representative immunohistochemistry image of ZEB1 staining (A82) of identical pairs of primary tissues and malignant ascites of colorectal (A111), gastric (A82) and pancreatic (A18) cancer (n = 10). Scale bars: 50 μm genes. 19 Therefore, we performed IHC of pSMAD2 as a surrogate marker for TGF-beta activity to determine if ATC can be stimulated by TGF-beta. The ATC were positive for pSMAD2 in all samples (10/ 10 100%; Figure 4A and Table 1 ). In contrast, pSMAD2 staining of identical primary tissues was only focally positive ( Figure 4A ). Furthermore, multiplex qPCR showed that signal transducers of TGFbeta signaling, such as SMAD1, SMAD2 and SMAD3, were highly expressed in ATC ( Figure 4B ). These results suggest that TGF-beta signaling is sufficiently activated in malignant ascites and contributes to the acquisition of ATC-specific properties. To evaluate the concentration of TGF-beta 1 in malignant ascites, we performed an ELISA of the supernatant of ascites fluid. TGF-beta 1 was detected in all patients (n = 38), including those with colorectal (n = 14), gastric (n = 17) and pancreatic cancers (n = 7). The median concentration of TGF-beta 1 in the ascites fluids was 968.6 pg/mL ( Figure 4C ), which could sufficiently affect ATC phenotype and function. To identify the cell population that secretes TGF-beta 1, we purified ATC and AMC by FACS analysis and evaluated the gene expression of TGF-beta 1 by qPCR. It is noteworthy that higher TGF-beta 1 expression was observed in lymphocytes and myeloid cells compared to ATC (Figure S5A) , suggesting that TGF-beta 1 is mainly secreted by AMC. In particular, patients with a high frequency of NK cells had a high concentration of TGF-beta 1 ( Figure S5B ). These results indicated that the ATC-specific properties were affected by TGF-beta 1 released from the ascites microenvironment.
| Transforming growth factor beta 1 induces epithelial-mesenchymal transition with CD44 + CSClike cells in vitro
To test whether TGF-beta 1 secreted from ascites microenvironment could contribute to ATC-specific properties such as high
Transforming growth factor beta-1 (TGF-beta 1) is abundantly released from the ascites microenvironment. A, Representative immunohistochemistry image of pSMAD2 staining (A82) of identical pairs of primary tissues and malignant ascites of colorectal (A111), gastric (A82) and pancreatic (A18) cancer (n = 10). Scale bars: 50 μm. B, The dot plot indicates that the relative expression of SMAD1, SMAD2 and SMAD3 was higher in malignant ascites (n = 15; black dots for gastric cancer, red dots for colorectal cancer and blue dots for pancreatic cancer) than in primary tissues (n = 15; black dots for gastric cancer and red dots for colorectal cancer), as determined by quantitative PCR (qPCR). Two-tailed Student's t test was used for statistical analysis. **P < 0.01; ***P < 0.001. C, The dot plot indicates TGF-beta 1 production in the supernatant of ascites fluid (n = 38). The red bar and the value indicate the median of the group CD44 expression and mesenchymal-like features, we cultured ATC from patients in vitro. FACS analysis showed that the cultured ATC were positive for EpCAM, suggesting that they maintained the epithelial phenotype ( Figure 5A ). TGF-beta 1 treatment (TGF-beta 1, 10 ng/mL) morphologically changed the ATC phenotype into spindle-shaped cells, suggesting that mesenchymal-like features were conferred. With this morphological change, TGF-beta 1 upregulated the gene expression of SNAI1, TWIST1, vimentin and N-cadherin concomitant with E-cadherin downregulation in cultured ATC ( Figure 5D ). These results clearly indicated that the TGF-beta signaling pathway induced the EMT in cultured ATC in vitro. Surprisingly, the frequency of CD44-positive cells in these cultured ATC was significantly higher after TGF-beta 1 treatment, as determined by FACS analysis ( Figure 5D ). Taken together, we showed the important role of TGF-beta 1 in maintaining the properties of ATC. To evaluate the functional role of ATC properties, we performed the sphere-forming assay to assess whether TGF-beta 1 treatment contributes to CSC properties. TGF-beta 1 treatment induced sphereforming ability in cultured ATC, whereas control cells only had slightly formed spheres ( Figure 5C ). These results suggested that TGF-beta 1-treated cultured ATC acquired CSC-like properties with the EMT in vitro.
| DISCUSSION
In various malignancies, ascites is a sign of advanced disease and poor prognosis, with only 11% of patients surviving longer than 6 months. 20 The characteristics of ATC might contribute to the poor prognosis of patients with malignant ascites. Here, we showed Taking into account the signal transduction of the ATC, the genetic status of TGF-beta-related genes should be discussed. Generally, somatic mutations of TGF-beta signaling-related genes are reported to contribute to unresponsiveness to TGF-beta-induced EMT. 24 In particular, SMAD4 mutation occurs in 32% of pancreatic cancer, 25 16% of non-hyper-mutated colorectal cancer 26 and 8% of non-hyper-mutated gastric cancer patients. 27 Dominant negative mutation of SMAD2, SMAD3 and SMAD4 resulted in unresponsiveness to TGF-beta-induced EMT through disruption of canonical SMAD-mediated TGF-beta signaling, although EMT can be induced in control cells by TGF-beta stimulation. 28 However, a recent study revealed SMAD-independent activation of TGF-beta signaling 29 through other pathways, such as ERK pathway, PI3-kinase/AKT pathway and Rho-like GTPase pathway, in response to TGF-beta. These SMAD-independent pathways might contribute to the EMT phenotype in SMAD4-mutated gastrointestinal cancer. In our IHC analysis, all samples (10 out of 10 patients) were positive for pSMAD2, suggesting that SMAD-mediated TGF-beta signaling was activated in our 10 patients. However, in consideration of the high frequency of SMAD4 mutation in gastrointestinal cancer, a certain number of SMAD4 mutated patients could be included in the other results of our data. The SMAD-independent pathway might contribute to the characteristic phenotype of ATC in SMAD4-mutated patients in some way. Mutation of TGFBR2, the representative receptor of TGF-beta, which causes its loss of function as a signal transducer of TGF-beta signaling, should also be discussed. More than 50% of hyper-mutated colorectal cancer 26 and hyper-mutated gastric cancer, 30 and 5% of pancreatic cancer 25 had a TGFBR2 mutation. In fact, EMT cannot be induced in TGFBR2-mutated colon cancer cell lines because of inactivated TGFBR2-mediated TGF-beta signaling, 31 while EMT phenotype can be induced in cell lines with wild-type TGFBR2 by TGF-beta stimulation. However, in view of its lower frequency, the effect of 
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